Disruption of iron homeostasis increases phosphine toxicity in Caenorhabditis elegans.
The aim of this study is to identify the biochemical mechanism of phosphine toxicity and resistance, using Caenorhabditis elegans as a model organism. To date, the precise mode of phosphine action is unclear. In this report, we demonstrate the following dose-dependent actions of phosphine, in vitro: (1) reduction of ferric iron (Fe3+) to ferrous iron (Fe2+), (2) release of iron from horse ferritin, (3) and the peroxidation of lipid as a result of iron release from ferritin. Using in situ hybridization, we show that the ferritin genes of C. elegans, both ferritin-1 and ferritin-2, are expressed along the digestive tract with greatest expression at the proximal and distal ends. Basal expression of the ferritin-2 gene, as determined by quantitative PCR, is approximately 80 times that of ferritin-1. However, transcript levels of ferritin-1 are induced at least 20-fold in response to phosphine, whereas there is no change in the level of ferritin-2. This resembles the reported pattern of ferritin gene regulation by iron, suggesting that phosphine toxicity may be related to an increase in the level of free iron. Indeed, iron overload increases phosphine toxicity in C. elegans at least threefold. Moreover, we demonstrate that suppression of ferritin-2 gene expression by RNAi, significantly increases sensitivity to phosphine. This study identifies similarities between phosphine toxicity and iron overload and demonstrates that phosphine can trigger iron release from storage proteins, increasing lipid peroxidation, leading to cell injury and/or cell death.
Cha'on
Ubon
U
School of Molecular and Microbial Sciences, The University of Queensland, St Lucia, QLD 4072 Australia.
Valmas
Nicholas
N
Collins
Patrick J
PJ
Reilly
Paul E B
PE
Hammock
Bruce D
BD
Ebert
Paul R
PR
D000818:Animals; D017173:Caenorhabditis elegans / Q000187:drug effects* / Q000378:metabolism; D002712:Chlorides; D004305:Dose-Response Relationship, Drug; D005290:Ferric Compounds / Q000737:chemistry; D005293:Ferritins / Q000096:biosynthesis* / Q000737:chemistry / Q000235:genetics; D005296:Ferrous Compounds / Q000378:metabolism; D015801:Helminth Proteins / Q000096:biosynthesis* / Q000235:genetics; D006706:Homeostasis / Q000187:drug effects; D007306:Insecticides / Q000737:chemistry / Q000633:toxicity*; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects; D007501:Iron / Q000737:chemistry / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000187:drug effects; D010084:Oxidation-Reduction / Q000187:drug effects; D010720:Phosphines / Q000737:chemistry / Q000633:toxicity*; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D034622:RNA Interference; D012333:RNA, Messenger / Q000096:biosynthesis; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects
D002712:Chlorides; D005290:Ferric Compounds; D005296:Ferrous Compounds; D015801:Helminth Proteins; D007306:Insecticides; D010720:Phosphines; D000644:Quaternary Ammonium Compounds; D012333:RNA, Messenger; D005293:Ferritins; C038178:ammonium ferrous sulfate; D007501:Iron; C044646:phosphine; C024555:ferric chloride